# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-004908
Filing Date
2025-01-13
Accepted
2025-01-13 06:07:03
Documents
34
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d901878d8k.htm iXBRL | 8-K | 26627
2 | EX-99.1 | d901878dex991.htm | EX-99.1 | 20191
6 | GRAPHIC | g901878ex99_1p10g1.jpg | GRAPHIC | 225421
7 | GRAPHIC | g901878ex99_1p11g1.jpg | GRAPHIC | 256378
8 | GRAPHIC | g901878ex99_1p12g1.jpg | GRAPHIC | 217265
9 | GRAPHIC | g901878ex99_1p13g1.jpg | GRAPHIC | 244453
10 | GRAPHIC | g901878ex99_1p14g1.jpg | GRAPHIC | 226557
11 | GRAPHIC | g901878ex99_1p15g1.jpg | GRAPHIC | 239832
12 | GRAPHIC | g901878ex99_1p16g1.jpg | GRAPHIC | 165198
13 | GRAPHIC | g901878ex99_1p17g1.jpg | GRAPHIC | 135481
14 | GRAPHIC | g901878ex99_1p18g1.jpg | GRAPHIC | 147755
15 | GRAPHIC | g901878ex99_1p19g1.jpg | GRAPHIC | 216879
16 | GRAPHIC | g901878ex99_1p1g1.jpg | GRAPHIC | 118466
17 | GRAPHIC | g901878ex99_1p20g1.jpg | GRAPHIC | 49344
18 | GRAPHIC | g901878ex99_1p2g1.jpg | GRAPHIC | 408082
19 | GRAPHIC | g901878ex99_1p3g1.jpg | GRAPHIC | 206074
20 | GRAPHIC | g901878ex99_1p4g1.jpg | GRAPHIC | 211228
21 | GRAPHIC | g901878ex99_1p5g1.jpg | GRAPHIC | 162709
22 | GRAPHIC | g901878ex99_1p6g1.jpg | GRAPHIC | 249683
23 | GRAPHIC | g901878ex99_1p7g1.jpg | GRAPHIC | 178177
24 | GRAPHIC | g901878ex99_1p8g1.jpg | GRAPHIC | 246864
25 | GRAPHIC | g901878ex99_1p9g1.jpg | GRAPHIC | 207999
| Complete submission text file | 0001193125-25-004908.txt |  | 5850558

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | cprx-20250113.xsd | EX-101.SCH | 2872
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cprx-20250113_lab.xml | EX-101.LAB | 18758
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cprx-20250113_pre.xml | EX-101.PRE | 11725
37 | EXTRACTED XBRL INSTANCE DOCUMENT | d901878d8k_htm.xml | XML | 3812

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 25524649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)